0.00
—
Close of 30 Oct 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Imagenetix
Its shares trade under the ticker IAGX. It has been listed since 1 December 1993. In the fiscal year to 31 March 2015, it reported revenue of $824,499 and a net loss of $21,712. At that date it held total assets of $8.8m and shareholders' equity of $6.3m.
Imagenetix, Inc. develops, formulates and markets over-the-counter and natural-based nutritional supplements and skin care products. The company is headquartered in San Diego, California. The firm's products are offered through multiple channels of distribution, including direct marketing companies, also known as network marketing or multi-level marketing companies and chain store retailers. Its primary product is Celadrin, a product formulation, which it sells to the mass market through retailers and on a private label basis to wholesale customers. The firm licenses its intellectual property to third parties. The company is focused on two medical need areas, which include human and animal conditions related to inflammation and obesity. The company has researched and developed active compositions in the areas of joint health, arthritis and periodontal disease, among others. The firm sells its own branded product, Celadrin, directly to the mass markets through retail sellers. The company also offers Celadrin products through wholesale customers.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Consumer Staples
- Industry
- Personal Products
- Listed since
- 1 Dec 1993
- Employees
- 7
Leadership
Pay as last reported
- Mr. Robert DennisChairman of the Board, since 2015
- Mr. Decky GoodrichPresident, Chief Executive Officer, Director, since 2015
- Mr. Anthony OppermanVice Chairman of the Board, since 2015
- Mr. Lowell GiffhornChief Financial Officer, Secretary$194,215
- Dr. George GeorgaklisDirector
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Imagenetix Inc has a strong brand reputation in the market, with a portfolio of high-quality products. This brand recognition allows them to attract a large customer base and maintain customer loyalty.
- The company has a robust research and development team, which enables them to continuously innovate and introduce new products to the market. This helps Imagenetix to stay ahead of its competitors and cater to changing customer needs.
Weaknesses
- One of the weaknesses of Imagenetix Inc is its limited market presence. The company primarily operates in a niche market, which restricts its potential for growth and expansion.
- Imagenetix heavily relies on a single supplier for a key ingredient in its products. This dependency poses a risk to the company's supply chain and may lead to disruptions in production if issues arise with that supplier.
Opportunities
- There is a growing trend of health-conscious consumers seeking natural and organic products. Imagenetix can capitalize on this opportunity by expanding its product line to include more natural and organic options to cater to this increasing demand.
- The company can also explore new markets and regions to expand its customer base. By targeting emerging economies, Imagenetix can tap into previously untapped markets and gain a competitive edge.
Threats
- One of the major threats for Imagenetix Inc is the intense competition in the industry. There are several established players and new entrants constantly entering the market, which increases the competition for market share.
- Changes in regulations and compliance requirements for the ingredients used in Imagenetix's products can also pose a threat. Non-compliance or failure to adapt to changing regulations can lead to penalties, reputation damage, and loss of market share.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.